Glucosamine Clinical Trials Glucosamine RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
Conditions:   Coronavirus;   Covid19 Intervention:   Dietary Supplement: N-acetyl glucosamine (NAG) Sponsor:   Quantinosis.ai LLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials